Company Updates
Idol Announce USD$1 million Investment and New Strategic Partnership
Idol is very happy to announce a USD$1 million investment from Stratus Capital Pte., a Singapore based venture capital fund.
Soar Releases their ‘Token Generating Event’ Primer Document!
Soar, the global decentralised drone platform, has recently releeased their ‘Token Generating Event’ Primer Document to the public.
First Graphene (ASX: FGR) Sign MoU with newGen Group
First Graphene Limited and newGen Group sign Memorandum of Understanding to developed mining materials that incorporate graphene.
Parkway Minerals (ASX: PWN) Raises $500,000 to support Davenport Resources
Parkway Minerals raised $500,000 in private placement. Funds will be used to participate in placement for Davenport Resources. Davenport is endeavouring to establish Europe’s largest potato inventory.
Mobilicom (ASX: MOB) launch MCU-mini and SkyHopper mobile controllers
Mobilicom release MCU-mini Controller and SkyHopper.
Mobilicom fifth product launch as part of their aggressive first-year execution plan.
Oddup adds cryptocurrency price targets and ratings to its growing spectrum of insights
Oddup, the leading global provider of startup, investment, ICO, and cryptocurrency insights, announced the launch of its latest product addition – cryptocurrency price targets and ratings.
Vortex Fluidic Device set to make First Graphene (ASX: FGR) leader in the industry
First Graphene Limited and Flinders University’s Nanoscale Science and Technology launch new associate company, 2D Fluidics Pty Ltd.
Executive Chairman Paul Poli’s Presentation at Gold Coast Investment Showcase June 2018
Matsa Resources presented their opportunity at the Gold Coast Investment Showcase on the 20th of June
Xeophin Pty Ltd announces the launch of it’s Pre ICO & ICO raise using Blockchain technologies in Europe and Asia
Xeophin is focused on imunomodulating technologies & is committed to the research, development and commercialisation of new and novel medical treatments, in a number of high growth therapeutic areas
Backed By Leading Investment Groups and Family Offices
